JNJ - Better Coronavirus Stock: Johnson & Johnson or Emergent BioSolutions?
Any list of companies in the thick of the battle against novel coronavirus disease COVID-19 absolutely needs to include Johnson & Johnson (NYSE: JNJ) and Emergent BioSolutions (NYSE: EBS). Johnson & Johnson is the largest healthcare company in the world with tremendous resources. Emergent BioSolutions ranks as arguably the top biotech focused on public health threats.
Emergent BioSolutions has been the bigger winner so far in 2020. Is shares have soared close to 50%, while J&J's share price is nearly where it was at the start of the year. But which of these coronavirus-focused stocks is the better pick for long-term investors?
Image source: Getty Images.